genomics market

Top Reports

08 Dec 2023  |  North America

Growth Opportunities in Single Cell Genomics and Proteomics in the United States

Public Funding and Large Biopharma Investments Support Technological Advancements and Improved Analysis

In recent years, single-cell analysis has changed rapidly. It began as a niche, specialized technology with few companies offering solutions, which then became commonly used in academia. Subsequently, its use has spread to areas such as biopharma, with more companies investing in the research and development (R&D) of single-cell analysis projects. ...

$4,950.00
03 Sep 2019  |  North America

Global Single Cell Genomics and Proteomics Market, Forecast to 2023

Clinical Applications for Single Cell Analysis Remain a Heavily Uncontested Market Place

Single cell genomic and proteomics tools have gained significant importance in the past 2 years. The year 2018 was particularly very active with a lot of platforms made available by both established life sciences tools companies and start-ups. 10X Genomics and Fluidigm have demonstrated the potential for high-throughput single cell applications. Th...

$1,500.00

Special Price $1,125.00 save 25 %

This issue of Vital Signs, released on November 23, 2009, provides a strategic overview of trends in pharmacogenomic testing and drug development. Additionally, a company spotlight is provided for Paratek Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of innovative new therapies that treat and prevent ...

$1,500.00

Special Price $1,125.00 save 25 %

This issue of Vital Signs, released on February 4, 2008, provides an strategic overview of the integration of genomics technology in proteomics analysis. Additionally, a company spotlight is provided for MSM Protein Technologies, an emerging biotechnology company with a suite of tools for drug discovery of functional antibodies and proteins against...

$1,500.00

Special Price $1,125.00 save 25 %

This issue of Vital Signs, released on August 27, 2007, provides a strategic overview of emerging market opportunities for life sciences companies as they relate to direct-to-consumer genetic testing and personal genomics. Additionally, a company spotlight is provided for SeqWright DNA Technology Services, a provider of custom DNA sequencing and re...

$1,500.00

Special Price $1,125.00 save 25 %

This research service outlines the key developments in the field of functional genomics.

$4,950.00

Special Price $3,712.50 save 25 %

20 Dec 2006  |  North America

Strategic Analysis of U.S. Genomics Markets

 

This research service provides a strategic analysis of genomics markets within the United States. The market was divided into the total U.S. nucleic acid isolation markets, total U.S. PCR markets, total U.S. qRT-PCR markets, total U.S. DNA microarray markets, and total U.S. DNA sequencing technology markets. Each segment covers market trends, tech...

$4,950.00

Special Price $3,712.50 save 25 %

This strategic analysis service provides a detailed analysis of the European pharmacogenomics market. An indepth analysis of marketing parameters (revenues, forecasts, geographic trends and market share) coupled with competitive factors and strategies for sustained market prevalence are reported.

$4,950.00

Special Price $3,712.50 save 25 %

This research service analyzes emerging technologies in the field of pharmacogenomics and their impact on the healthcare industry

$3,950.00

Special Price $2,962.50 save 25 %

27 Jun 2005  |  Asia Pacific

Genomics and Proteomics Markets in Australia

 

The report covers the major attributes of Genomics and Proteomics Markets in Australia. The Executive summary gives the details of teh report in brief. A separate analysis of the Genomics and Proteomics markets have been done giving details about the market size from the year 2002-2007. Apart from this, a total market analysis was done along with c...

$3,950.00

Special Price $2,962.50 save 25 %

This research service tracks, analyzes and profiles emerging technologies, especially genomics and proteomics for drug discovery in Europe

$3,950.00

Special Price $2,962.50 save 25 %

04 Oct 2002  |  North America

U.S. Functional Genomics Market

 

Only 2 to 3 percent of the Human Genome sequence contains regulatory information. Knowing how genes are regulated can open a wide field of commercial opportunities, some of which are being persued under the umbrella term of functional genomics. This field spans mutational (wetlab) and expression analysis (microarray) technologies, and is tied toge...

$2,450.00

Special Price $1,837.50 save 25 %

06 Jun 2001  |  North America

U.S. Pharmacogenomics Markets

 

The U.S. Pharmacogenomics Market report focuses on the varying dynamics of the pharmacogenomics market. This report covers the Pharmacogenomics services, Gene-based Diagnostics, and Orphan Drugs segments. This report provides an in-depth analysis of the revenue sales forecasts for the market, drivers and restraints that affect the current and futu...

$3,950.00

Special Price $2,962.50 save 25 %

$3,950.00

Special Price $2,962.50 save 25 %

05 Nov 1998  |  Global

Opportunities in the Neurogenomics Market

 

 

$3,950.00

Special Price $2,962.50 save 25 %

 

$3,950.00

Special Price $2,962.50 save 25 %